12 Best Extremely Profitable Stocks to Buy Right Now

Page 8 of 11

4. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

TTM Net Profit Margin: 31.94%

Number of Hedge Fund Holders: 66

Analyst Upside Potential: 35.13%

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 22, Analyst Tim Anderson from Bank of America Securities reiterated a Sell rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) while reducing the price target from $535 to $504.

The bearish sentiment is primarily due to the challenges faced by the company’s Eylea franchise. Anderson expects the US sales of Eylea to decline significantly, leading to a below-market consensus EPS for 2025 and 2026. Moreover, the analyst is also concerned about the drug pricing pressures and increased competition from branded drugs and biosimilars. He noted the recent partial failure of Itepekimab, a key pipeline drug, which adds to the uncertainty around the company’s growth prospects.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a biotechnology company that develops and commercializes treatments for serious diseases.

Page 8 of 11